Anatara Historical Cash Flow
| ANR Stock | 0.06 0 1.72% |
Analysis of Anatara Lifesciences cash flow over time is an excellent tool to project Anatara Lifesciences future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Capital Expenditures of 3.8 or Total Cash From Financing Activities of 2.5 M as it is a great indicator of Anatara Lifesciences ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining Anatara Lifesciences latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Anatara Lifesciences is a good buy for the upcoming year.
Anatara |
About Anatara Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in Anatara balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Anatara's non-liquid assets can be easily converted into cash.
Anatara Lifesciences Cash Flow Chart
Add Fundamental
Begin Period Cash Flow
The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.Stock Based Compensation
Compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders.Most accounts from Anatara Lifesciences' cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Anatara Lifesciences current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Anatara Lifesciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. At this time, Anatara Lifesciences' Total Cash From Financing Activities is comparatively stable compared to the past year. End Period Cash Flow is likely to gain to about 1.8 M in 2024, whereas Free Cash Flow is likely to drop (1.3 M) in 2024.
Anatara Lifesciences cash flow statement Correlations
Click cells to compare fundamentals
Anatara Lifesciences Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Anatara Lifesciences cash flow statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Other Cashflows From Financing Activities | 4.0M | (514.0) | (17.4K) | (18.2K) | 50K | 47.5K | |
| End Period Cash Flow | 2.7M | 3.4M | 1.1M | 351.2K | 982.1K | 1.8M | |
| Change In Cash | 1.3M | 749.7K | (2.3M) | (769.0K) | 630.9K | 662.5K | |
| Free Cash Flow | (2.7M) | (2.1M) | (2.2M) | (2.3M) | (1.2M) | (1.3M) | |
| Change In Working Capital | 318.2K | (225.8K) | 199.9K | (330.4K) | 343.2K | 360.4K | |
| Begin Period Cash Flow | 1.4M | 2.7M | 3.4M | 1.1M | 351.2K | 333.6K | |
| Other Non Cash Items | 72.0K | 272.7K | (106.4K) | 442.9K | (170.4K) | (161.9K) | |
| Total Cash From Operating Activities | (2.7M) | (2.1M) | (2.2M) | (2.3M) | (1.2M) | (1.3M) | |
| Change To Account Receivables | 265.7K | (142.2K) | 264.0K | (495.6K) | 333.0K | 349.6K | |
| Net Income | (3.4M) | (2.0M) | (2.5M) | (2.0M) | (1.5M) | (1.5M) | |
| Investments | 4.1M | (4.0K) | (50K) | (1.7K) | 50K | 52.5K | |
| Total Cashflows From Investing Activities | 4.0M | (4.0K) | (56.6K) | (1.7K) | (2.0K) | (2.1K) | |
| Depreciation | 16.1K | 6.3K | 24.7K | 24.8K | 2.5K | 2.3K | |
| Change To Operating Activities | 4.7K | (6.7K) | (30.6K) | (7.9K) | (7.1K) | (7.5K) | |
| Change To Netincome | 305.5K | 117.9K | 74.8K | 70.9K | 63.8K | 60.6K | |
| Change To Liabilities | 47.8K | (76.9K) | (33.5K) | 173.1K | 155.8K | 163.6K | |
| Change To Inventory | (931.9K) | 732.8K | 64.1K | (165.2K) | (190.0K) | (180.5K) | |
| Stock Based Compensation | 305.7K | 117.6K | 71.5K | 54.6K | 28.6K | 27.2K |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Anatara Stock Analysis
When running Anatara Lifesciences' price analysis, check to measure Anatara Lifesciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Anatara Lifesciences is operating at the current time. Most of Anatara Lifesciences' value examination focuses on studying past and present price action to predict the probability of Anatara Lifesciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Anatara Lifesciences' price. Additionally, you may evaluate how the addition of Anatara Lifesciences to your portfolios can decrease your overall portfolio volatility.